Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

September 1, 2020 by Alan Khadavi

Risk for Peanut Allergy Severity

viaskin peanut patch

There is no current cure for peanut allergy. Accidental exposures are common and can be severe. To assess children who had severe reactions during oral peanut challenges, scientists identified certain biomarkers that would help them see who would be at higher risk with accidental ingestion of 0.1 gram of peanut protein (about half a peanut […]

Filed Under: Blog, Food allergy

August 27, 2020 by Alan Khadavi

Chronic Hives work up not essential or cost effective

chronic spontaneous urticaria

Chronic hives or chronic spontaneous urticaria or chronic idiopathic urticaria or chronic autoimmune urticaria is characterized by moving, itching wheals that occur with variable frequency for 6 weeks duration or more. Stepwise approach to Chronic Urticaria (Chronic Hives) It can occur in adults and pediatrics, but it is more common in adults. It is usually […]

Filed Under: Blog, hives, Urticaria

August 12, 2020 by Alan Khadavi

Dr. Alan Khadavi for Wikihow

wikihow videos

  Dr. Alan Khadavi recently helped collaborate on several allergy topics with Wikihow that were of interest to its readers. Please click on the links below for detailed descriptions on topics co-authored by Dr. Khadavi pertaining to allergies. How to prevent hay fever How to manage grass allergies How to patch test the skin How […]

Filed Under: Blog, Headlines

August 11, 2020 by Alan Khadavi

Covid with Xolair, Nucala, Cinqair, Fasenra or Dupixent for Asthma

Explore how camlipixant, a selective P2X3 antagonist, reduces cough frequency and improves quality of life in patients with refractory chronic cough.

As Covid-19 continues to spread around the world, there are concerns that patients with asthma will be at higher risk or poorer outcomes. There is also concern about whether asthma treatments could worsen the risk of disease or severity. Currently, asthma is not in the top 10 comorbidities associated with Covid-19 fatalities, obesity, diabetes and […]

Filed Under: biologics, Blog

July 29, 2020 by Alan Khadavi

Newborns born to Covid-19 Mothers

Newborns born to Covid-19 Mothers

Humans are susceptible to SARS-CoV-2 and pregnant women and newborns are potential at-risk groups for COVID-19. Coronavirus infections in pregnant women can cause adverse consequences, such as spontaneous miscarriage, preterm delivery and intrauterine growth restriction and stillbirth. As of now, there is no evidence of mother to child vertical transmission of SARS-CoV-2, it is important […]

Filed Under: Blog, Headlines

July 29, 2020 by Alan Khadavi

CVID and Covid-19, what are their outcomes?

covid vaccine and hives

SARS-CoV-2 has become the focus of scientific attention. The presentation of COVID-19 can range from lack of symptoms to severe respiratory distress and multiorgan failure requiring ICU admission and mechanical ventilation and eventual death. CVID (common variable immune deficiency) are characterized of having primary antibody deficiencies with defective antibody production (IgG).  A study published in the […]

Filed Under: Blog, Headlines, immune deficiency

July 2, 2020 by Alan Khadavi

New Treatment for Hives being studied

opzelura vs zoryve

The current only approved treatment for hives are antihistamines and Xolair (omalizumab). Omalizumab is approved for the treatment of chronic hives for those 12 years and older (it is approved for 6 years and older in asthma). New treatment for hives are on the horizon. Stepwise approach to Chronic Urticaria (Chronic Hives) Ligelizumab is a […]

Filed Under: biologics, Blog, hives

June 30, 2020 by Alan Khadavi

Cibinqo Abrocitinib for Atopic Dermatitis by Pfizer

abrocitinib

Cibinqo Abrocitinib is currently being developed by Pfizer for the treatment of atopic dermatitis (eczema). It is an investigational oral once-daily Janus kinase 1 (JAK1) inhibitor. The JAK/STAT pathway is an important factor in inflammation and itch in atopic dermatitis.  There are multiple receptors and signaling cascades involved in eczema related inflammation and itch, one […]

Filed Under: biologics, Blog, Medications

June 29, 2020 by Alan Khadavi

Is Clarinex safe during Pregnancy?

allegra during pregnancy

Is Clarinex safe during pregnancy? Clarinex, generic name is desloratadine does not have safety data to use during pregnancy. Loratadine (Claritin) has been previously studied and found no risk of adverse fetal outcomes during pregnancy and is considered safe. Desloratadine is the main active metabolite of Loratadine. In a previous post we described the difference […]

Filed Under: Allergy Medicine, Blog, Pediatric

June 29, 2020 by Alan Khadavi

Breztri new inhaler for COPD by AstraZeneca

breztri

Breztri is a new inhaler that will be approved for COPD. Breztri is a combination of 3 medications, budesonide/glycopyrronium/formoterol fumarate. Each of these medications have been used to treat COPD (chronic obstructive pulmonary disease), and used in combination, it has been shown to decrease the rate of moderate or severe exacerbations. We have spoken about […]

Filed Under: Asthma, Blog

  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 57
  • Next Page »

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page